These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 35047549)
1. Understanding the Effects of Antipsychotics on Appetite Control. Mukherjee S; Skrede S; Milbank E; Andriantsitohaina R; López M; Fernø J Front Nutr; 2021; 8():815456. PubMed ID: 35047549 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents. Miyamoto S; Miyake N; Jarskog LF; Fleischhacker WW; Lieberman JA Mol Psychiatry; 2012 Dec; 17(12):1206-27. PubMed ID: 22584864 [TBL] [Abstract][Full Text] [Related]
4. Effects of antipsychotic medications on appetite, weight, and insulin resistance. Deng C Endocrinol Metab Clin North Am; 2013 Sep; 42(3):545-63. PubMed ID: 24011886 [TBL] [Abstract][Full Text] [Related]
5. Serotonin receptors: their key role in drugs to treat schizophrenia. Meltzer HY; Li Z; Kaneda Y; Ichikawa J Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974 [TBL] [Abstract][Full Text] [Related]
6. Serotonergic mechanisms as targets for existing and novel antipsychotics. Meltzer HY Handb Exp Pharmacol; 2012; (212):87-124. PubMed ID: 23129329 [TBL] [Abstract][Full Text] [Related]
7. Update on typical and atypical antipsychotic drugs. Meltzer HY Annu Rev Med; 2013; 64():393-406. PubMed ID: 23020880 [TBL] [Abstract][Full Text] [Related]
8. The role of serotonin receptors in the action of atypical antipsychotic drugs. Meltzer HY; Massey BW Curr Opin Pharmacol; 2011 Feb; 11(1):59-67. PubMed ID: 21420906 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of typical and atypical antipsychotic drugs on striosome and matrix compartments of the striatum. Bubser M; Deutch AY Eur J Neurosci; 2002 Feb; 15(4):713-20. PubMed ID: 11886451 [TBL] [Abstract][Full Text] [Related]
10. Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities. Touré JT; Brandt NJ; Limcangco MR; Briesacher BA Am J Geriatr Pharmacother; 2006 Mar; 4(1):25-35. PubMed ID: 16730618 [TBL] [Abstract][Full Text] [Related]
11. Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes. Chen J; Huang XF; Shao R; Chen C; Deng C Front Neurosci; 2017; 11():643. PubMed ID: 29209160 [TBL] [Abstract][Full Text] [Related]
12. Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics. Baptista T; Zárate J; Joober R; Colasante C; Beaulieu S; Páez X; Hernández L Curr Drug Targets; 2004 Apr; 5(3):279-99. PubMed ID: 15058313 [TBL] [Abstract][Full Text] [Related]
13. [Schizophrenia, diabetes mellitus and antipsychotics]. Gury C Encephale; 2004; 30(4):382-91. PubMed ID: 15538314 [TBL] [Abstract][Full Text] [Related]
14. Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes. Silvestre JS; Prous J Methods Find Exp Clin Pharmacol; 2005 Jun; 27(5):289-304. PubMed ID: 16082416 [TBL] [Abstract][Full Text] [Related]
15. AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents. Black MD; Stevens RJ; Rogacki N; Featherstone RE; Senyah Y; Giardino O; Borowsky B; Stemmelin J; Cohen C; Pichat P; Arad M; Barak S; De Levie A; Weiner I; Griebel G; Varty GB Psychopharmacology (Berl); 2011 May; 215(1):149-63. PubMed ID: 21181124 [TBL] [Abstract][Full Text] [Related]
16. Regional differences in the action of antipsychotic drugs: implications for cognitive effects in schizophrenic patients. Beninger RJ; Baker TW; Florczynski MM; Banasikowski TJ Neurotox Res; 2010 Nov; 18(3-4):229-43. PubMed ID: 20376711 [TBL] [Abstract][Full Text] [Related]
17. Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents. Toren P; Ratner S; Laor N; Weizman A Drug Saf; 2004; 27(14):1135-56. PubMed ID: 15554747 [TBL] [Abstract][Full Text] [Related]